Skip to main content Skip to page footer

Hepatobiliary tumors

Logo des NCT Heidelberg Logo des NCT Heidelberg

Hepatobiliary tumors

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Treatment

Title: A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib VS Physician's Choice in Subjects With FGFR-altered, Chemotherapy- and FGFR Inhibitor-Cholangiocarcinoma
Phase: III
Contact: Anne-Charlotte Bernhardt / Study Nurse
Email-Address: Anne-Charlotte.Bernhardt(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. Dr.Christoph Springfeld
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05948475
EudraCT-Number: Keine Registernummer angegeben.

Title: Phase I/IIa, First-in-human (FIH), Open-label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of CLDN6 CAR-T With or Without CLDN6 RNA-LPX in Patients With CLDN6-positive Relapsed or Refractory Advanced Solid Tumors
Phase: I/II
Contact: Monika Pipa / Kontaktperson
Email-Address: Monika.Pipa(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Guy Ungerechts
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04503278
EudraCT-Number: Siehe EU klinisches Studienregister 2019-004323-20

Title: A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific TCER® Targeting PRAME, in Patients With Recurrent and/or Refractory Solid Tumors
Phase: I/II
Contact: Angela Diana Klein / Kontaktperson
Email-Address: AngelaDiana.Klein(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Jessica Hassel
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05958121
EudraCT-Number: Siehe EU klinisches Studienregister 2022-503133-54-00

Title: An Open-label, Phase I/II Multicenter Clinical Trial of NECVAX-NEO1 in Addition to Anti-PD-1 or Anti-PD-L1 Monoclonal Antibody Therapy in Patients With Solid Tumors
Phase: I/II
Contact: Mirjam Campbell / Kontaktperson
Email-Address: Mirjam.Campbell(at)med.uni-heidelberg.de
Clinical Investigator: Dr. med. Sebastian Martin Thomas Dieter
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06631079
EudraCT-Number: Keine Registernummer angegeben.

Surgical Study

There are currently no studies available

Radiotherapy Study

Title: Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases - MAESTRO -
Phase: II
Contact: Studienambulanz Strahlentherapie / Kontaktperson
Email-Address: studien.radonk(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Juliane Hörner-Rieber
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05027711
EudraCT-Number: Keine Registernummer angegeben.

Other study

Title: Studie zur Erstellung eines Registers des Liver Cancer Center Heidelberg
Phase: N/A
Contact: Dr.rer.nat. Aurelie Tomczak / Kontaktperson
Email-Address: Aurelie.Tomczak(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Thomas Longerich
Registration: Die Studie ist beim Deutschen Register Klinischer Studien registriert. DRKS00019901
EudraCT-Number: Keine Angabe. Nicht-interventionelle Studien oder Studien, die nicht unter das Arzneimittelgesetz fallen, besitzen keine EudraCT-Nummer.